about
Anaerobes and bacterial vaginosis in pregnancy: virulence factors contributing to vaginal colonisationInfluence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections.Silver sucrose octasulfate (IASOS™) as a valid active ingredient into a novel vaginal gel against human vaginal pathogens: in vitro antimicrobial activity assessment.The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term.Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysisPrevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity.Diagnostic and therapeutic advancements for aerobic vaginitis.Selecting anti-microbial treatment of aerobic vaginitis.Efficacy of oral moxifloxacin for aerobic vaginitis.Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities.The bacterial microbiome in paired vaginal and vestibular samples from women with vulvar vestibulitis syndrome.Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis.Factors influencing the development of a personal tailored microbiota in the neonate, with particular emphasis on antibiotic therapy.Microbiota of the upper and lower genital tract.Influence of contraceptive choice on vaginal bacterial and fungal microflora.Abnormal vaginal flora in symptomatic non-pregnant and pregnant women in a Greek hospital: a prospective study.Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota.A new era of the vaginal microbiome: advances using next-generation sequencing.A population-based study of the risk of repeat clinical chorioamnionitis in Washington State, 1989-2008.Diversity of Vaginal Lactic Acid Bacterial Microbiota in 15 Algerian Pregnant Women with and without Bacterial Vaginosis by using Culture Independent Method.Probiotics and nutrients for the first 1000 days of life in the developing world.Improvement of abnormal vaginal flora in Ugandan women by self-testing and short use of intravaginal antimicrobials.Increased vaginal pH in Ugandan women: what does it indicate?Maternal risk factors for abnormal vaginal flora during pregnancy.Diagnosis of aerobic vaginitis by quantitative real-time PCR.Neonatal invasive Haemophilus influenzae disease in England and Wales: epidemiology, clinical characteristics, and outcome.Lactobacillus-deficient vaginal microbiota dominate post-partum women in rural Malawi.Prevalence of vaginal microorganisms among pregnant women according to trimester and association with preterm birth.The Role of Skin and Orogenital Microbiota in Protective Immunity and Chronic Immune-Mediated Inflammatory Disease.Vaginal Microbiomes Associated With Aerobic Vaginitis and Bacterial Vaginosis.Streptococcus agalactiae Inhibits Candida albicans Hyphal Development and Diminishes Host Vaginal Mucosal TH17 Response.Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.The Vaginal Microenvironment: The Physiologic Role of Lactobacilli.Entzündliche Genitalerkrankungen — Teil 1
P2860
Q28243717-F5585482-9260-4DFC-B893-E714E37D554DQ31125863-7CF802FE-E755-45C3-9C41-FBC23E344E11Q31162492-B25B2F0B-B7A7-4795-985E-C1C0651AD38CQ33789021-2BC64393-CD26-41B4-9F83-94F35D5BC682Q34231180-ABCB5FBF-33F8-4BF0-8F14-F7E914CCB2AFQ34329978-0CE48BDD-FB3A-40B3-B095-0C8E1E3332F1Q34446129-2FF86362-6DDB-4D68-A8F4-BA43A83A7D85Q34472797-31CA44E2-8426-44DC-A0D7-F43958168AA9Q34500206-CB9145EC-FD2F-4BBA-8D05-21A4EFEF8F2FQ34510759-4821A1D6-EE3F-4B8E-AEE5-282122328719Q34674485-D6FC8AE7-044E-40BF-B676-329432EC742AQ34745905-E556790D-9883-4350-9C7B-EB8F140A806AQ34995449-92F59BAA-AC1A-428C-9AC7-78B5F9E0D480Q35624293-5796017D-A44E-4792-BD50-3BDD2605AA99Q36135994-09E6BB16-3192-4F30-9802-5045B1515595Q36163375-EBAF3393-588C-4813-B2B7-CA80B7A09A04Q36171542-D856A289-3D91-41B0-93B7-BFCB69D4C0F4Q36453097-F8E2AD89-C589-4FF8-8AF1-186FC79E7EADQ36653530-B74491B1-0BD8-42C0-97F1-A43FC9E76CEFQ37352938-30489FBC-67F9-4485-A999-478AD21B6FF1Q38068981-18725408-EB3F-45D9-BC1A-E3C453434C43Q38851896-59518EEE-7BC1-4358-A7F7-4EB79EE25830Q38854581-92E8C0BC-A60E-4B4F-B6D2-7E702D3D77C9Q40792382-992C55E8-7FC1-431E-A8A2-5E1BB50A2A1DQ40967983-1F7870B9-9FF4-47F9-AB33-023E98B2EAFBQ41417082-1FAA1441-FF3B-430C-A3AA-93A1716FD509Q47557671-4DBB2185-F2D2-437A-8BCA-B10055FD2B6CQ48161981-39EA8EB4-689A-42B4-918C-74B8AC35F51CQ49283907-58270DF8-604A-439E-8557-1B2368FF801FQ52597463-1D3D22C9-92DB-48BF-9E5F-0538EA4CCBA7Q54258297-58E553CD-0CDA-400F-974A-979DBF5B9692Q54992441-55FDA397-259B-426D-99B3-6823927E7991Q55408374-8B0A0E12-9EF7-4CEF-BCAF-216465889F54Q57098335-DA332A00-B099-41DD-B782-8020BFAC09E7
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Aerobic vaginitis in pregnancy.
@ast
Aerobic vaginitis in pregnancy.
@en
Aerobic vaginitis in pregnancy.
@nl
type
label
Aerobic vaginitis in pregnancy.
@ast
Aerobic vaginitis in pregnancy.
@en
Aerobic vaginitis in pregnancy.
@nl
prefLabel
Aerobic vaginitis in pregnancy.
@ast
Aerobic vaginitis in pregnancy.
@en
Aerobic vaginitis in pregnancy.
@nl
P2093
P2860
P1476
Aerobic vaginitis in pregnancy.
@en
P2093
D Rezeberga
Ggg Donders
P2860
P304
P356
10.1111/J.1471-0528.2011.03020.X
P577
2011-06-14T00:00:00Z